Unum Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Unum Therapeutics (UMRX) IPO Opens Modestly Lower
March 29, 2018 10:58 AM EDTToday's IPO for Unum Therapeutics Inc. (NASDAQ: UMRX) opened for trading at $11.75 pricing of its initial public offering of 5,770,000 shares of common stock at a public offering price of $12 per share.
In addition, Unum Therapeutics has granted the underwriters a 30-day option to... More
